• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

持久的 c-Jun N 端激酶 1(JNK1)激活导致 Sirtuin 1(SIRT1)蛋白降解,从而导致肥胖中的肝脂肪变性。

Sirtuin 1 (SIRT1) protein degradation in response to persistent c-Jun N-terminal kinase 1 (JNK1) activation contributes to hepatic steatosis in obesity.

机构信息

Antioxidant and Gene Regulation Laboratory, Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, Louisiana 70808, USA.

出版信息

J Biol Chem. 2011 Jun 24;286(25):22227-34. doi: 10.1074/jbc.M111.228874. Epub 2011 May 3.

DOI:10.1074/jbc.M111.228874
PMID:21540183
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3121368/
Abstract

SIRT1 is involved in the pathogenesis of obesity, diabetes, and aging. However, it is not clear how SIRT1 activity is regulated by intracellular kinases in cells. In this study, we investigated SIRT1 phosphorylation and protein degradation in response to JNK1 activation in obese mice. Mouse SIRT1 is phosphorylated by JNK1 at Ser-46 (Ser-47 in human SIRT1), which is one of the four potential residues targeted by JNK1. The phosphorylation induces a brief activation of SIRT1 function and degradation of SIRT1 thereafter by the proteasome. Ubiquitination occurs in SIRT1 protein after the phosphorylation. Mutation of Ser-46 to alanine prevents the phosphorylation, ubiquitination, and degradation. In vivo, SIRT1 undergoes an extensive degradation in hepatocytes in obesity as a consequence of persistent activation of JNK1. The degradation leads to inhibition of SIRT1 function, which contributes to development of hepatic steatosis. The degradation disappears in obesity when JNK1 is inactivated in mice. JNK2 exhibits an opposite activity in the regulation of SIRT1 degradation. The JNK1-SIRT1 pathway provides a new molecular mechanism for the pathogenesis of hepatic steatosis in obesity.

摘要

SIRT1 参与肥胖、糖尿病和衰老的发病机制。然而,细胞内激酶如何调节 SIRT1 活性尚不清楚。在这项研究中,我们研究了肥胖小鼠中 JNK1 激活时 SIRT1 的磷酸化和蛋白降解。小鼠 SIRT1 可被 JNK1 在 Ser-46(人 SIRT1 中的 Ser-47)磷酸化,这是 JNK1 靶向的四个潜在残基之一。磷酸化诱导 SIRT1 功能短暂激活,随后通过蛋白酶体降解 SIRT1。磷酸化后 SIRT1 蛋白发生泛素化。将 Ser-46 突变为丙氨酸可阻止磷酸化、泛素化和降解。在肥胖的肝细胞中,由于 JNK1 的持续激活,SIRT1 经历广泛降解。这种降解导致 SIRT1 功能抑制,这有助于肝脂肪变性的发展。当小鼠中 JNK1 失活时,这种降解在肥胖中消失。JNK2 在 SIRT1 降解的调节中表现出相反的活性。JNK1-SIRT1 通路为肥胖症中肝脂肪变性的发病机制提供了新的分子机制。

相似文献

1
Sirtuin 1 (SIRT1) protein degradation in response to persistent c-Jun N-terminal kinase 1 (JNK1) activation contributes to hepatic steatosis in obesity.持久的 c-Jun N 端激酶 1(JNK1)激活导致 Sirtuin 1(SIRT1)蛋白降解,从而导致肥胖中的肝脂肪变性。
J Biol Chem. 2011 Jun 24;286(25):22227-34. doi: 10.1074/jbc.M111.228874. Epub 2011 May 3.
2
c-Jun N-terminal kinase-1 from hematopoietic cells mediates progression from hepatic steatosis to steatohepatitis and fibrosis in mice.造血细胞中的c-Jun氨基末端激酶-1介导小鼠肝脏脂肪变性向脂肪性肝炎和肝纤维化的进展。
Gastroenterology. 2009 Oct;137(4):1467-1477.e5. doi: 10.1053/j.gastro.2009.06.045. Epub 2009 Jun 21.
3
Combined Activities of JNK1 and JNK2 in Hepatocytes Protect Against Toxic Liver Injury.肝细胞中JNK1和JNK2的联合活性可预防中毒性肝损伤。
Gastroenterology. 2016 Apr;150(4):968-81. doi: 10.1053/j.gastro.2015.12.019. Epub 2015 Dec 19.
4
Phosphorylation and degradation of S6K1 (p70S6K1) in response to persistent JNK1 Activation.响应持续的JNK1激活,S6K1(p70S6K1)的磷酸化和降解
Biochim Biophys Acta. 2013 Dec;1832(12):1980-8. doi: 10.1016/j.bbadis.2013.06.013. Epub 2013 Jun 28.
5
c-Jun N-terminal kinase 1/c-Jun activation of the p53/microRNA 34a/sirtuin 1 pathway contributes to apoptosis induced by deoxycholic acid in rat liver.c-Jun N-末端激酶 1/c-Jun 激活的 p53/微小 RNA 34a/沉默调节蛋白 1 通路有助于脱氧胆酸诱导的大鼠肝凋亡。
Mol Cell Biol. 2014 Mar;34(6):1100-20. doi: 10.1128/MCB.00420-13. Epub 2014 Jan 13.
6
JNK1 phosphorylates SIRT1 and promotes its enzymatic activity.JNK1 磷酸化 SIRT1 并促进其酶活性。
PLoS One. 2009 Dec 22;4(12):e8414. doi: 10.1371/journal.pone.0008414.
7
Prevention of steatosis by hepatic JNK1.通过肝 JNK1 预防脂肪变性。
Cell Metab. 2009 Dec;10(6):491-8. doi: 10.1016/j.cmet.2009.09.007.
8
c-Jun N-terminal protein kinase 1 (JNK1), but not JNK2, is essential for tumor necrosis factor alpha-induced c-Jun kinase activation and apoptosis.c-Jun氨基末端蛋白激酶1(JNK1)而非JNK2,对于肿瘤坏死因子α诱导的c-Jun激酶激活和细胞凋亡至关重要。
Mol Cell Biol. 2004 Dec;24(24):10844-56. doi: 10.1128/MCB.24.24.10844-10856.2004.
9
Hepatic SIRT1 attenuates hepatic steatosis and controls energy balance in mice by inducing fibroblast growth factor 21.肝 SIRT1 通过诱导成纤维细胞生长因子 21 减轻小鼠肝脂肪变性并控制能量平衡。
Gastroenterology. 2014 Feb;146(2):539-49.e7. doi: 10.1053/j.gastro.2013.10.059. Epub 2013 Nov 1.
10
JNK1 ablation in mice confers long-term metabolic protection from diet-induced obesity at the cost of moderate skin oxidative damage.小鼠体内JNK1基因缺失可使其免受饮食诱导的肥胖带来的长期代谢影响,但代价是皮肤受到中度氧化损伤。
FASEB J. 2016 Sep;30(9):3124-32. doi: 10.1096/fj.201600393R. Epub 2016 May 26.

引用本文的文献

1
Targeting TGF-β-Smad2/3-JNK1-mediated SIRT1 activity overcomes the chemoresistance of KRAS mutation lung cancer.靶向转化生长因子-β-信号转导分子Smad2/3-应激活化蛋白激酶1介导的沉默信息调节因子1活性可克服KRAS突变型肺癌的化疗耐药性。
Exp Mol Med. 2025 Sep 12. doi: 10.1038/s12276-025-01536-8.
2
Nutrients as epigenetic modulators in metabolic dysfunction-associated steatotic liver disease.营养素作为代谢功能障碍相关脂肪性肝病中的表观遗传调节剂。
World J Hepatol. 2025 Aug 27;17(8):108182. doi: 10.4254/wjh.v17.i8.108182.
3
Targeting p21-Positive Senescent Chondrocytes via IL-6R/JAK2 Inhibition to Alleviate Osteoarthritis.通过抑制IL-6R/JAK2靶向p21阳性衰老软骨细胞以减轻骨关节炎
Adv Sci (Weinh). 2025 Mar;12(11):e2410795. doi: 10.1002/advs.202410795. Epub 2025 Jan 23.
4
The Structures, Functions, and Roles of Class III HDACs (Sirtuins) in Neuropsychiatric Diseases.III 类组蛋白去乙酰化酶(Sirtuins)的结构、功能和在神经精神疾病中的作用。
Cells. 2024 Oct 2;13(19):1644. doi: 10.3390/cells13191644.
5
Protein posttranslational modifications in metabolic diseases: basic concepts and targeted therapies.代谢性疾病中的蛋白质翻译后修饰:基本概念与靶向治疗
MedComm (2020). 2024 Sep 30;5(10):e752. doi: 10.1002/mco2.752. eCollection 2024 Oct.
6
Gut microbiota-derived indole-3-propionic acid alleviates diabetic kidney disease through its mitochondrial protective effect via reducing ubiquitination mediated-degradation of SIRT1.肠道微生物群衍生的吲哚-3-丙酸通过其线粒体保护作用减轻糖尿病肾病,该作用通过减少泛素化介导的SIRT1降解来实现。
J Adv Res. 2024 Aug 13. doi: 10.1016/j.jare.2024.08.018.
7
Excess glucose alone depress young mesenchymal stromal/stem cell osteogenesis and mitochondria activity within hours/days via NAD/SIRT1 axis.过量葡萄糖可通过 NAD/SIRT1 轴在数小时/数天内单独抑制年轻间充质基质/干细胞的成骨作用和线粒体活性。
J Biomed Sci. 2024 May 13;31(1):49. doi: 10.1186/s12929-024-01039-0.
8
Bioactive Compounds as Inhibitors of Inflammation, Oxidative Stress and Metabolic Dysfunctions via Regulation of Cellular Redox Balance and Histone Acetylation State.生物活性化合物通过调节细胞氧化还原平衡和组蛋白乙酰化状态作为炎症、氧化应激和代谢功能障碍的抑制剂。
Foods. 2023 Feb 22;12(5):925. doi: 10.3390/foods12050925.
9
Bone marrow mesenchymal stem cell-derived exosomal lncRNA KLF3-AS1 stabilizes Sirt1 protein to improve cerebral ischemia/reperfusion injury via miR-206/USP22 axis.骨髓间充质干细胞衍生的外泌体 lncRNA KLF3-AS1 通过 miR-206/USP22 轴稳定 Sirt1 蛋白,改善脑缺血/再灌注损伤。
Mol Med. 2023 Jan 10;29(1):3. doi: 10.1186/s10020-022-00595-1.
10
Role of Post-translational Modification of Silent Mating Type Information Regulator 2 Homolog 1 in Cancer and Other Disorders.沉默交配型信息调节因子2同源物1的翻译后修饰在癌症及其他疾病中的作用
J Cancer Prev. 2022 Sep 30;27(3):157-169. doi: 10.15430/JCP.2022.27.3.157.

本文引用的文献

1
Lack of SIRT1 (Mammalian Sirtuin 1) activity leads to liver steatosis in the SIRT1+/- mice: a role of lipid mobilization and inflammation.SIRT1(哺乳动物沉默调节蛋白 1)活性缺乏导致 SIRT1+/- 小鼠肝脂肪变性:脂质动员和炎症的作用。
Endocrinology. 2010 Jun;151(6):2504-14. doi: 10.1210/en.2009-1013. Epub 2010 Mar 25.
2
Role of the hypothalamic-pituitary-thyroid axis in metabolic regulation by JNK1.JNK1 在代谢调节中的作用:下丘脑-垂体-甲状腺轴。
Genes Dev. 2010 Feb 1;24(3):256-64. doi: 10.1101/gad.1878510. Epub 2010 Jan 15.
3
JNK1 phosphorylates SIRT1 and promotes its enzymatic activity.JNK1 磷酸化 SIRT1 并促进其酶活性。
PLoS One. 2009 Dec 22;4(12):e8414. doi: 10.1371/journal.pone.0008414.
4
Prevention of steatosis by hepatic JNK1.通过肝 JNK1 预防脂肪变性。
Cell Metab. 2009 Dec;10(6):491-8. doi: 10.1016/j.cmet.2009.09.007.
5
Activation of SIRT1 by resveratrol represses transcription of the gene for the cytosolic form of phosphoenolpyruvate carboxykinase (GTP) by deacetylating hepatic nuclear factor 4alpha.白藜芦醇激活SIRT1可通过使肝细胞核因子4α去乙酰化来抑制磷酸烯醇式丙酮酸羧激酶(GTP)胞质型基因的转录。
J Biol Chem. 2009 Oct 2;284(40):27042-53. doi: 10.1074/jbc.M109.047340. Epub 2009 Aug 3.
6
SirT1 knockdown in liver decreases basal hepatic glucose production and increases hepatic insulin responsiveness in diabetic rats.在糖尿病大鼠肝脏中敲低SirT1可降低基础肝糖生成并增强肝脏对胰岛素的反应性。
Proc Natl Acad Sci U S A. 2009 Jul 7;106(27):11288-93. doi: 10.1073/pnas.0812931106. Epub 2009 Jun 22.
7
Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation.肝脏特异性敲除SIRT1会改变脂肪酸代谢,导致肝脏脂肪变性和炎症。
Cell Metab. 2009 Apr;9(4):327-38. doi: 10.1016/j.cmet.2009.02.006.
8
Phosphorylation regulates SIRT1 function.磷酸化作用调节沉默信息调节因子1(SIRT1)的功能。
PLoS One. 2008;3(12):e4020. doi: 10.1371/journal.pone.0004020. Epub 2008 Dec 24.
9
Differential effects of JNK1 and JNK2 inhibition on murine steatohepatitis and insulin resistance.JNK1和JNK2抑制对小鼠脂肪性肝炎和胰岛素抵抗的不同影响。
Hepatology. 2009 Jan;49(1):87-96. doi: 10.1002/hep.22578.
10
A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange.一种禁食诱导开关通过激活剂/共激活剂交换调节糖异生。
Nature. 2008 Nov 13;456(7219):269-73. doi: 10.1038/nature07349. Epub 2008 Oct 5.